TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Wellgistics Health Inc ( (WGRX) ) just unveiled an announcement.
On November 20, 2025, Wellgistics Health Inc. reported its third-quarter financial results, highlighting a significant net operating loss of $33.878 million, primarily due to increased stock-based compensation. The company is focusing on the launch of Brenzavvy for the Type 2 diabetes market and the integration of its EinsteinRx AI pharmacy hub software, which aims to reduce out-of-pocket costs for patients. Additionally, Wellgistics is expanding its GLP-1 drug offerings and plans to launch products to mitigate side effects, while also distributing a supplement targeting Long COVID. The company terminated its acquisition of Peek Healthcare Technologies, Inc. as it no longer aligns with its strategic plans.
More about Wellgistics Health Inc
Wellgistics Health Inc. is a health information technology company that focuses on optimizing the delivery of medications from manufacturers to patients. The company connects over 6,500 pharmacies and 200 manufacturers, offering services such as wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services. Wellgistics aims to restore access, transparency, and trust in U.S. healthcare.
Average Trading Volume: 14,614,480
Technical Sentiment Signal: Strong Sell
Current Market Cap: $51.88M
Learn more about WGRX stock on TipRanks’ Stock Analysis page.